[Therapeutic benefits and adverse effects of extended idebenone treatment in Leber hereditary optic neuropathy (LHON)]
HTA Region Stockholm
Record ID 32018014811
English
Original Title:
Förlängd behandlingsduration med idebenon – Effekter, biverkningar och kostnader
Details
Project Status:
Completed
Year Published:
2025
URL for published report:
https://www.chis.regionstockholm.se/4afb28/globalassets/verksamheter/chis/hta/rapporter/forlangd-behandlingsduration-med-idebenon.pdf
English language abstract:
There is no English language summary available
Publication Type:
Full HTA
Country:
Sweden
MeSH Terms
- Optic Atrophy, Hereditary, Leber
- Mitochondrial Diseases
- Ubiquinone
- Antioxidants
- Visual Acuity
Keywords
- Optic Atrophy Hereditary Leber
- Mitochondrial diseases
- Ubiquinone
- Idebenone
- LHON
- Antioxidants
- Leber's Hereditary Optic Neuropathy
Contact
Organisation Name:
HTA Region Stockholm
Contact Address:
HTA Region Stockholm, Centre for Health Economics, Informatics and Health Care Research (CHIS) Stockholm Health Care Services,Sweden
Contact Name:
Eva Fjellgren
Contact Email:
eva.fjellgren@regionstockholm.se
Copyright:
HTA Region Stockholm
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.